Nyrada (ASX:NYR), a drug discovery company focused on small molecule therapies, has announced the successful completion of ...

Pro Medicus Limited (ASX:PME), a leading player in healthcare informatics, has announced a significant five-year contract ...

Challenger (ASX:CGF) posted strong first-quarter results for FY25, with total assets under management increasing to $128 ...

The Reject Shop (ASX:TRS) delivered a robust performance in FY24, reporting record sales of $852.7 million, a 4.1% increase ...

Bank of Queensland (ASX: BOQ) has announced its FY24 results, reporting a significant rise in statutory net profit after tax ...

Oil prices plunged over 4% to a near two-week low on Tuesday, driven by a weaker demand outlook and a report indicating that ...

Engineering services company Monadelphous Group (ASX:MND) has announced a series of new contracts and extensions valued at ...

Australian shares fell, following losses on Wall Street, driven by reduced demand for natural resource-related assets. At ...

AI-powered healthcare company Enlitic (ASX:ENL) has secured two major distribution agreements with Bayer Healthcare and ...

The Australian economy is less sensitive to China than it used to be, but a stimulus driven cyclical boost to the Chinese economy is still positive for the Australian economy, share market and the $A.

Preliminary efficacy data indicates that all three participants in this cohort experienced reductions in prostate-specific antigen (PSA) levels, with the most substantial decrease recorded at 95.7%.

Nico Resources Limited (Nico) is wholly focused on its Wingellina Nickel-Cobalt Project (Wingellina or the Project).